DUBLIN--(BUSINESS WIRE)--The "2022 Flow Cytometry Life Science Dashboard Series 2 (NA & EMEA)" report has been added to ResearchAndMarkets.com's offering. This 2022 Dashboard provides a snapshot of the current market landscape for flow cytometry reag
DUBLIN--(BUSINESS WIRE)--The "North America Pallet Market Report and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. North America pallet market attained a volume of about 1,563.9 billion units in 2021. Aided by a flourish
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI) (the “Company” or “Appili”) announced the closing of its previously anno
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, today announced that it plans to complete a private placement fina
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD ; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and
NEW YORK--(BUSINESS WIRE)--Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization (TPS) as a novel therapeutic modality, today announced that Eddine Saiah, Ph.D., has joined the company as Chief Scientific Officer. Dr. Saiah
Total revenue increased by 9% to $15.4 million in the quarter Non-clinic revenue increased by 45% to $0.9 million in the quarter 13th consecutive quarter of positive adjusted EBITDA(1) Fueling future growth with completion of three new fluoroscopy
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (TSXV: GSP, AIM: GSP) is pleased to announce the
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is pleased to announce the closing of the first tranche of a Priva
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.